Stem Cell Agency Finance Subcommittee Meeting October 12, 2010

Oct 12, 2011
Main Location: 

CIRM
210 King Street
San Francisco, CA 94107

Additional Locations: 
628 Pacific View Drive San Diego, CA 91209
Stanford University School of Medicine LKSC 291 Campus Drive LK3CO2, 3rd Floor Stanford, CA 94305-5101
Reeve-Irvine Research Center 1105 Gillespie Neuroscience Research Facility (GNRF) 837 Health Science Road University of California at Irvine School of Medicine Irvine, CA 92697-4292
7011 East Ave Livermore, CA 94550
Klein Financial Corporation 550 California Avenue, Suite 330 Palo Alto, CA 94306
San Francisco City Attorney's Office San Francisco International Airport International Terminal, 5th Floor San Francisco, CA 94128

Stem Cell Agency Finance Subcommittee Meeting


MEETING NOTICE AND AGENDA

REGULAR MEETING
FINANCE SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

OPEN SESSION

1. Call to Order.

2. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

3. Consideration of amendments to and adoption of Loan Administration Policy.

4. Consideration of Strategic Financial Plan Projected Cash Flows.

#4A: PROPOSED FUNDING TIMELINE

5. Consideration of Proposal for CIRM-Funded Electronic Journal.

6. Consideration of Loan Application for Early Translational II Research Award.

CLOSED SESSION

7. Consideration of confidential or proprietary financial information relating applications for Early Translational II Research Awards. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

OPEN SESSION

Report back from Closed Session if necessary.

8. Public Comment.

9. Adjournment.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizen’s Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov
 

© 2013 California Institute for Regenerative Medicine